Leading the way to safer medication
 Crosscheck  Recommender

DepoCyte 50 mg suspension for injection (2011)

Product Name and Form

DepoCyte 50 mg suspension for injection.

Pharmaceutical form

Suspension for injection.

White to off-white suspension.

Qualitative and Quantitative Composition

One ml of suspension contains 10 mg cytarabine.

Each 5 ml vial contains 50 mg cytarabine.

For a full list of excipients, see section 6.1.

List of excipients

Cholesterol
Triolein
Dioleoylphosphatidylcholine (DOPC)
Dipalmitoylphosphatidylglycerol (DPPG)
Sodium chloride
Water for injections

Pack sizes and Marketing

Type I glass vial closed with a fluororesin faced butyl rubber stopper and sealed with an aluminium flip-off seal containing 50 mg cytarabine in 5 ml suspension.

DepoCyte is supplied in individual cartons each containing one single-dose vial.

Marketing authorization holder
Authorization dates

Pacira Limited
3 Glory Park Avenue
Wooburn Green
High Wycombe
Buckinghamshire
HP10 0DF
United Kingdom

Date of first authorisation: 11 July 2001

Marketing authorization number:

EU/1/01/187/001